Your fact-checks will appear here
A condition that can progress to dementia, and the effects of donepezil on it.
Clinical and preclinical literature describes repeated low-dose methylene blue (MB) as a candidate neuroprotective and memory‑enhancing agent via mitochondrial and anti‑oxidant actions, with human ima...
Existing dementia drugs like donepezil produce small-to-moderate, short‑to‑medium term symptomatic benefits on cognition, global clinical state and daily function, but high‑quality evidence that they ...
Randomized controlled trials specifically testing honey for mild cognitive impairment (MCI) or Alzheimer’s disease do not exist in the published literature . Cinnamon has been evaluated in a tiny clin...